BACKGROUND: Left atrial appendage flow velocity (LAAFV) and presence of spontaneous echo contrast (SEC) have been reported to be predictors of thromboembolism in atrial fibrillation (AF) patients. Galectin-3 is a biomarker reflecting pro-inflammatory status, whose role in AF has recently drawn attention, particularly in persistent AF population. AIM: In this study we aimed to investigate the association between serum galectin-3 levels and echocardiographic predictors of thromboembolism in persistent AF patients. METHODS: We included 65 persistent AF patients (55.50±10.67 years, 46.15% male). Transesophageal echocardiography (TEE) was performed to assess LAAFV and presence of left atrial (LA)/LA appendage (LAA)-located SEC and thrombus prior to direct current cardioversion or catheter ablation for AF. RESULTS: Median galectin-3 level was 0.63 ng/mL. Serum galectin-3 levels were significantly correlated with LAAFV (r=-.440, P<.001). Serum galectin-3 levels were associated with presence of SEC (P<.001), and LA thrombus (P=.008). Receiver operating characteristic analysis revealed that a serum galectin-3 greater or equal to the cut-off value of 0.69 predicted presence of SEC with a sensitivity and specificity of 91.00% and 79.00%, respectively (P<.001). CONCLUSION: In conclusion, in the setting of persistent AF, serum galectin-3 levels are associated with presence of SEC and LAAFV on TEE. Our findings suggest that serum galectin-3 level may have a place in thromboembolism risk stratification in persistent AF patients.
BACKGROUND: Left atrial appendage flow velocity (LAAFV) and presence of spontaneous echo contrast (SEC) have been reported to be predictors of thromboembolism in atrial fibrillation (AF) patients. Galectin-3 is a biomarker reflecting pro-inflammatory status, whose role in AF has recently drawn attention, particularly in persistent AF population. AIM: In this study we aimed to investigate the association between serum galectin-3 levels and echocardiographic predictors of thromboembolism in persistent AFpatients. METHODS: We included 65 persistent AFpatients (55.50±10.67 years, 46.15% male). Transesophageal echocardiography (TEE) was performed to assess LAAFV and presence of left atrial (LA)/LA appendage (LAA)-located SEC and thrombus prior to direct current cardioversion or catheter ablation for AF. RESULTS: Median galectin-3 level was 0.63 ng/mL. Serum galectin-3 levels were significantly correlated with LAAFV (r=-.440, P<.001). Serum galectin-3 levels were associated with presence of SEC (P<.001), and LA thrombus (P=.008). Receiver operating characteristic analysis revealed that a serum galectin-3 greater or equal to the cut-off value of 0.69 predicted presence of SEC with a sensitivity and specificity of 91.00% and 79.00%, respectively (P<.001). CONCLUSION: In conclusion, in the setting of persistent AF, serum galectin-3 levels are associated with presence of SEC and LAAFV on TEE. Our findings suggest that serum galectin-3 level may have a place in thromboembolism risk stratification in persistent AFpatients.
Authors: Muhammed U Yalcin; Kadri M Gurses; Duygu Kocyigit; Hande Canpinar; Ugur Canpolat; Banu Evranos; Hikmet Yorgun; Mehmet L Sahiner; Ergun B Kaya; Tuncay Hazirolan; Lale Tokgozoglu; Mehmet A Oto; Necla Ozer; Dicle Guc; Kudret Aytemir Journal: J Cardiovasc Electrophysiol Date: 2015-03-27
Authors: R W Asinger; J Koehler; L A Pearce; M Zabalgoitia; J L Blackshear; P E Fenster; R Strauss; D Hess; G D Pennock; R M Rothbart; J L Halperin Journal: J Am Soc Echocardiogr Date: 1999-12 Impact factor: 5.251
Authors: M K Chung; D O Martin; D Sprecher; O Wazni; A Kanderian; C A Carnes; J A Bauer; P J Tchou; M J Niebauer; A Natale; D R Van Wagoner Journal: Circulation Date: 2001-12-11 Impact factor: 29.690
Authors: Maria Albertina Romaniuk; Maria Virginia Tribulatti; Valentina Cattaneo; Maria Jose Lapponi; Felisa Concepcion Molinas; Oscar Campetella; Mirta Schattner Journal: Biochem J Date: 2010-12-15 Impact factor: 3.857
Authors: Natalia Pacienza; Roberto G Pozner; Germán A Bianco; Lina P D'Atri; Diego O Croci; Soledad Negrotto; Elisa Malaver; Ricardo M Gómez; Gabriel A Rabinovich; Mirta Schattner Journal: FASEB J Date: 2007-11-05 Impact factor: 5.191
Authors: Julia Etulain; Soledad Negrotto; María Virginia Tribulatti; Diego Omar Croci; Julieta Carabelli; Oscar Campetella; Gabriel Adrián Rabinovich; Mirta Schattner Journal: PLoS One Date: 2014-04-30 Impact factor: 3.240